CSDXCS Diagnostics Corp.

About CS Diagnostics Corp. (CSDX)

CS Diagnostics Corp. (CSDX) is a Medical Devices company headquartered in Neuss, Germany whose shares trade over-the-counter on the OTCQB tier.

CS Diagnostics Corp. a renowned member of the CS Group, is a medical sector leader committed to advancing patient care through innovative solutions. With decades of experience in designing, manufacturing, and selling wellness and medical products, we have established ourselves as a reliable partner in global healthcare. Our team of experienced professionals works closely with top universities and experts to ensure we remain at the forefront of medical technology. Our flagship product, CS Protect Hydrogel is a pioneering advancement of medical innovation. This novel spacer gel is especially developed to distinguish between healthy and malignant cells during radiation therapy, greatly increasing the recovery outcomes for prostate cancer patients. By increasing therapy effectiveness, CS Protect Hydrogel demonstrates our commitment to improving patient experiences and outcomes. CS Diagnostics Corp. serves a varied international market and specializes at traversing complicated regulatory landscapes to gain product approval and distribution. Our global presence is enhanced by strategic collaborations with healthcare sectors globally, ensuring that our comprehensive services and solutions are available in multiple countries. With a focus on quality and a strong range of solutions, CS Diagnostics Corp. is well-positioned to change the future of healthcare by delivering on our promise of greater health through better technology.

Products and services

ISO 13485 and ISO 9001 certified international distribution and development of pharmaceuticals and medical devices.

CSDX key facts

Ticker symbol

CSDX

Market tier

OTCQB

Sector

Healthcare

Industry

Medical Devices

Headquarters

Neuss, Germany

Country of incorporation

US

Year of incorporation

2010

Employees

16

Estimated market cap

$20.88M (as of Apr 11, 2025)

Shares outstanding

137,340,200

Reporting standard

Alternative Reporting Standard

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

CS Diagnostics Corp. leadership

• Thomas Fahrhoefer — President
• Thomas Josef Migotsch — Vice President, COO
• Mohammad EsSayed — Vice President, CFO
• Elizabeth Pearce — Other
• Llewellyn Angus — Other
• John Hereward West — Other
• Janel Luzana — Company Secretary

Explore more: Medical Devices stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with C